You already hold genetic data — genotype files, SNP data or a full genomic database — but no product to earn from it? Novogenia turns that data into a revenue stream. We interpret the relevant genetic markers, translate them into personalized supplements and cosmetics and manufacture the finished products in our own, certified EU lab — under your brand. You commercialize the genetic data you already own, and open a new revenue stream, without building a lab or a factory.
Genotype files, SNP data or a genomic database are the expensive part of personalized nutrition — and you already hold it. The missing piece is a product to sell from it.
Raw genotype and SNP data you already own are interpreted against the relevant genetic markers — no need to build a new lab or start from scratch.
Each genetic profile is translated into individual personalized supplements and cosmetics — the right formula per person, not a one-size-fits-all product.
We produce the finished personalized products in our own certified EU lab — from small batches up, Made in Austria, EU standard.
Formula, packaging and fulfillment carry your brand as a white-label solution — the revenue and the customer stay with you, Novogenia stays invisible.
A supplement is consumed and reordered, so the same genetic data point can power a subscription-friendly product line — genetic data monetization that lasts.
We have run our own certified EU genetic lab since 2009 and developed more than 30 genetic tests — the science behind the product is ours, not outsourced.
You generate revenue from SNP data without capital-heavy infrastructure. We contribute the interpretation, formulation, manufacturing and fulfillment.
Interpretation, formulation, manufacturing, packaging and fulfillment come from a single source, so you coordinate one partner instead of five suppliers.
Production to EU requirements in Salzburg — a trust argument you can pass straight to your end customers.
You keep ownership of the genetic data and the customer relationship. We are your production partner, not a competitor for your audience.
From a first pilot line to a full personalized range, we grow with you as a long-term manufacturing partner.
Many companies sit on valuable genetic data — from a DNA test, a lab, a research project or a customer database — but have no way to earn from it beyond the one-time analysis. Novogenia is the missing link that lets you commercialize genetic data: we interpret the SNP data, translate it into personalized supplements and cosmetics and manufacture them in our own certified EU lab. You keep the brand, the data and the customer; we deliver the product that generates the new revenue stream.
Turn your data into revenue →If your company already holds genetic data — genotype files, SNP data, DNA-test results or a customer database — you are sitting on an asset that most competitors never manage to turn into recurring income. A genetic test is usually a one-time sale, and the data behind it often just sits in storage. Monetizing genetic data means putting that asset back to work: turning a genomic database into physical, personalized products that customers buy, run out of and reorder. Novogenia specializes in exactly this step. We interpret the relevant genetic markers, translate them into personalized supplements and cosmetics and manufacture the finished products in our own certified EU lab — so a static database becomes an active revenue stream.
The result is a bridge from data to revenue: you keep the genetic data, the brand and the customer relationship, while we contribute the interpretation, the formulation logic and the manufacturing. Instead of building a lab, a formulation team and a production line yourself, you plug into an existing, validated infrastructure and open a new product revenue stream far faster.
This is built for organizations that already have access to genetic information and want to generate revenue from genetic data: DNA testing companies looking for downstream products, genetic laboratories that analyze but do not manufacture, health and longevity platforms with genotype data, research groups with genomic databases, and brands that have run genetic tests and now want to commercialize the data. If you can supply the data, we can supply the product that earns from it.
The reason so much genetic data stays unmonetized is that turning it into a product traditionally means owning a lab, a formulation team and a production line. Novogenia removes that barrier. You bring the DNA database; we contribute everything downstream — interpretation, formulation, manufacturing and fulfillment — from our own certified EU lab. You open a new revenue stream from genetic data without the capital, the risk or the years it would take to build that infrastructure yourself.
The value is in the translation from genetics to a concrete recommendation. Novogenia has developed more than 30 genetic tests and maps genetic markers to specific needs — which nutrients a person is likely to require more of, which form is best absorbed, and where a standard product would miss. This nutrigenetic rule set is what converts an anonymous SNP profile into an individual formula, and it is the same science behind our own personalized product lines.
Personalization only becomes revenue if production can actually deliver a different formula per person. Novogenia manufactures in its own certified EU lab in Salzburg, from small batches up, so individualized products are practical rather than theoretical. On request, active ingredients are delivered through our Microtransporter slow-release technology, which releases nutrients in fast, slow or 50:50 profiles for better tolerance and steadier levels. Everything is produced to EU standard — Made in Austria — which is a strong trust signal to pass on to your end customers.
The entire chain runs as a white-label solution. Formula, packaging, inserts and fulfillment carry your brand; Novogenia never appears to the outside. You own the data and the customer relationship, so the revenue stays with you, and we act purely as the production partner in the background — never as a competitor for your audience.
A genetic test is bought once, but a personalized supplement is consumed and reordered. That is what makes this the strongest way to monetize a genomic database: the same data point can power a recurring, subscription-friendly product line for years. We support fulfillment and reorders so a single analysis becomes a lasting revenue stream rather than a one-time sale.
Depending on your starting point, you may also want to look at turning genetic data into supplements, follow-up products for genetic testing companies or recurring revenue from personalized supplements. To discuss how to monetize your specific data, get in touch with our team or ask our AI assistant.
Tell us what genetic data you hold and what products you want to build on it — we'll come back with a concept for interpretation, formulation and manufacturing under your brand. Or ask our AI assistant directly, around the clock.